LifeMap Sciences’ Next Generation Sequencing Analysis Platform and Integrated Biomedical Knowledgebases for empowered life sciences research and precision medicine

TGex™ - Knowledge Driven NGS Analysis

TGex is a powerful, easy to use, full flow NGS Analysis and Interpretation platform. Powered by the GeneCardsSuite, it offers rapid biological interpretation & prioritization, automated evidence-driven reports, and is available on cloud or on premises.


VarElect Phenotype Driven Analysis

VarElect Phenotype
Driven Analysis

Integrated Annotation and Interpretation

Integrated Annotation &
Interpretation View

Automatic, Customizable Report Generation

Automatic, Customizable
Report Generation

Automatic, Customizable Report Generation

Cloud or on Premises
and Integrable


Learn More...

GeneCards Suite Integrated Biomedical Knowledgebase

Effectively navigate the universe of biological entities - genes, proteins, cells, biological pathways and diseases, and the connections between them.

Learn More...


20 January 2016

LifeMap Sciences, a Subsidiary of BioTime, Announces the Launch of TGex, the Knowledge-Driven NGS Analysis Platform, Powered by the GeneCards Suite

LifeMap Sciences, Inc. (“LifeMap”), a life sciences technology company and subsidiary of BioTime, Inc., announced today the market launch of TGex™ (Translational Genomics Expert), an integrated next-generation genomic sequencing (NGS) analysis platform. TGex leverages the GeneCards Suite Knowledgebase to rapidly identify genetic variants that may impact disease management and health outcomes, eliminating a traditional research bottleneck and enabling streamlined, efficient exploration and utilization of sequencing data for research, as well as exploring diagnostic and therapeutic utility in the rapidly growing, global NGS market. TGex™ was developed in partnership with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd.

Read more
Featured Customers
LifeMap’s products are used in more than 3,000 institutions in academia, research hospitals, national patent offices, and leading biopharma and diagnostic companies, including: